Business · 30/12/2013Updated: 10/17/2026 · 1 min read
Strategies To Address Hemolytic Complications of Immune Globulin Infusions; Public Workshop
Summary
The FDA is hosting a public workshop to discuss strategies for addressing hemolytic complications associated with immune globulin infusions, a topic of growing concern for patients and healthcare providers.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →